Skip to content Skip to footer
Subscribe Now
NEWS

Vir Biotechnology and Gilead Enter ~$1.87B Deal to Develop PRO-XTEN Dual-Masked T-Cell Engagers for Solid Tumors

Shots: Vir has entered into a collaboration & license agreement with Gilead to discover & engineer 3 novel PRO-XTENdual-masked T-cell engager (TCE) development candidates targeting selected solid tumor-associated antigens  As per the deal, Vir will discover, design, & optimize three PRO-XTEN dual-masked TCE candidates, while Gilead will hold exclusive rights to nominate & advance them,…
2 days ago

Read more

NEWS

Enodia Therapeutics Inks Over $500M Deal with Pfizer to Develop Sec61-Targeting Small Molecules

Shots: Enodia Therapeutics has entered into a research collaboration & license agreement with Pfizer to discover & develop Sec61-targeting small-molecule therapeutics leveraging Enodia’s platform As per the deal, Enodia will screen, optimize, & develop Sec61 inhibitor candidates against multiple collaboration targets, while Pfizer will assume responsibility for clinical development, manufacturing, regulatory affairs, & commercialization after…
2 days ago

Read more

EVENTS

Evolution Summit 2027 | January 19-20 | Four Seasons Hotel Westlake Village, CA

The Evolution Summit will take place 19-20 January 2027 at the Four Seasons Hotel in Westlake Village, California. This invitation-only summit brings together senior clinical development leaders to benchmark strategies for strengthening trial execution, accelerating development timelines and navigating the evolving regulatory and technology landscape. The program covers AI implementation in clinical operations, ICH E6(R3)…
October 7, 2026

Read more

THOUGHTSPOT

How Does SIGMAR1 Recombinant Protein Help Study Alzheimer’s Disease?

Neurons are specialized nerve cells in the brain and nervous system that continuously communicate. At the same time, our brain produces and clears proteins, mitochondria generate energy, and the endoplasmic reticulum (ER) maintains protein and calcium balance. These processes work together to keep neurons healthy and functioning properly.  However, when this cellular balance is disrupted,…
October 1, 2026

Read more

NEWS

Earendil Labs Inks $1.5B+ Research Collaboration with Genentech to Advance Bispecific Antibodies in Oncology

Shots: Earendil Labs has entered into a research collaboration with Genentech to discover and develop multiple therapeutic bispecific antibody programs in oncology Earendil Labs will lead antibody discovery & research through early clinical development for programs targeting certain pre-agreed target combinations, while Genentech will take over global clinical development & commercialization As per the deal,…
September 24, 2026

Read more

NEWS

QurCan Therapeutics Partners with Eli Lilly to Develop Nucleic Acid Therapies for CNS and PNS Diseases

Shots: QurCan Therapeutics has entered into an exclusive research & collaboration agreement with Eli Lilly for the treatment of diseases of the central nervous system (CNS) and peripheral nervous system (PNS) Lilly & QurCan will collaborate on multiple research programs focused on the development of PLNP-enabled genetic medicines for CNS & PNS delivery, with QurCan…
September 15, 2026

Read more

EVENTS

Digi-Tech Pharma & AI 2027 | May 11-12 | London, UK

The pharmaceutical and healthcare industries are entering a new era of technology-led transformation, with artificial intelligence, machine learning, data science, informatics, and advanced data management reshaping how medicines are discovered, developed, and delivered. Against this backdrop, Digi-Tech Pharma & AI 2027 will bring together senior professionals, technology leaders, decision-makers, and innovators from the pharmaceutical, biotechnology,…
August 19, 2026

Read more

Load more